Investigation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone for in vivo and in vitro murine embryopathy and embryonic ras mutations

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 1128-1135

  Winn, Louise M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CYTOCHROME P450; PHENOBARBITAL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; CARCINOGEN; NITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL TERATOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DETERMINATION; DOSE CALCULATION; DRUG POTENTIATION; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYOPATHY; EMBRYOTOXICITY; FEMALE; GENE MUTATION; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ONCOGENE RAS; PRENATAL EXPOSURE; PRIORITY JOURNAL; REACTION ANALYSIS; ANIMAL; CONGENITAL MALFORMATION; DRUG EFFECT; FETUS; METABOLISM; MUTATION; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PLANT; PREGNANCY; TOBACCO; ULTRASTRUCTURE;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; CARCINOGENS; EMBRYO; FEMALE; FETUS; GENES, RAS; MICE; MUTATION; NITROSAMINES; ORGAN CULTURE TECHNIQUES; PHENOBARBITAL; PLANTS, TOXIC; PREGNANCY; TOBACCO;

EID: 0032247478     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Adams JD, O'Mara-Adams KJ and Hoffmann D (1987) Toxic and carcinogenic agents in undiluted mainstream and sidestream smoke of different types of cigarettes. Carcinogenesis 8:729-731.
2. Alaoui-Jamali MA, Rossignol G, Schuller HM and Castonguay A (1989) Transplacental genotoxicity of a tobacco-specific N-nitrosamine, 4-(methylnitrosamino)-l(3-pyridyl)-l-butanone, in Syrian golden hamster. Mutation Res 223:65-72.
3. American Academy of Pediatrics Committee on Environmental Health (1997) Environmental tobacco smoke: A hazard to children. Pediatrics 99:639-642.
4. Anderson LM, Hecht SS, Dixon DE, Dove LF, Kovatch RM, Amin S, Hoffmann D ai d Rice JM (1989) Evaluation of the transplacental tumorgenicity of the tobaccaspecific carcinogen 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in mice. Ca,icer Res 49:3770-3775.
5. Belinsky SA, Devereux TR, Maronpot RR, Stoner GD and Anderson MW (1989) The relationship between the formation of promutagenic adducts and the activation rf the K-ras proto-oncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res 49:5305-5311.
6. Bishop JG and Corces VG (1988) Expression of an activated ras gene causes developmental abnormalities in transgenic drosophilia melanogaster. Genes Dev 2:56'i 577.
7. Blair PS, Fleming PJ, Bensley D, Smith I, Bacon C, Taylor E, Berry J, Golding J and Tripp J (1996) Smoking and the sudden infant death syndrome: results from 1993-5 case-control study for confidential inquiry into stillbirths and deaths in infancy. Br Med J 313:195-198.
8. Bos JL (1989) Ras oncogenes in human cancer. A review. Cancer Res 49:4682-4689.
9. Carmella SG, Akerkar S and Hecht SS (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in smokers urino. Cancer Res 53:721-724.
10. Castonguay A, Tjalve H, Trushin N and Hecht SS (1984) Perinatal metabolism of th e tobacco-specific carcinogen 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in C57BL mice. J Natl Cancer Inst 72:1117-1124.
11. Chianale J, Dvorak C, Farmer DL, Michaels L and Gumucio JJ (1988) Cytochrome P-450 gene expression in the functional units of the fetal liver. Hepatology 8:318326.
12. Correa E, Joshi PA, Castonguay A and Schuller HM (1990) The tobacco-specif c nitrosamine 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone is an active transplacental carcinogen in Syrian Golden hamsters. Cancer Res 50:3435-3438.
13. Cresteil T, Beaune P, Celier C, Leroux JP and Guengerich FP (1986) Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phénobarbital and 3-methylcholanthreno. J Pharm Exp Ther 236:269-276.
14. Everson RB, Randerath E, Santella RM, Avitts TA, Weinstein IB and Randerath K (1988) Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst 80:567-576.
15. Finnell RH, Bennett GD, Slattery JT, Amore BM, Bajpai M and Levy RH (199M Effect of treatment with phénobarbital and stiripentol on carbamazepine-inducei teratogenicity and reactive metabolite formation. Teratology 52:324-332.
16. Gibson JE and Becker BA (1968) Effect of phénobarbital and SKF 525-A on the teratogenicity of cyclophosphamide in mice. Teratology 1:393-398.
17. Harbison RD and Becker BA (1970) Effect of phénobarbital and SKF 525A pretrealment on diphenylhydantoin teratogenicity in mice. J Pharm Exp Ther 175:283288.
18. Hecht SS (1996) Recent studies on mechanisms of bioactivation and detoxification cf 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK), a tobacco-specific lun? carcinogen. Crit Rev Toxicol 22:163-181.
19. Hecht SS, Abbaspour A and Hoffmann D (1988) A study of tobacco Carcinogenesis XLII. Bioassay in A/J mice of some structural analogues of tobacco-specific nitre samines. Cancer Lett 42:141-145.
20. Hoffmann D and Hecht SS (1985) Nicotine-derived N-nitrosamines and tobacccrelated cancer: current status and future directions. Cancer Res 45:935-944.
21. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R and Jacks T (1997) K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Deu 11:2468-2481.
22. Juchau MR, Lee QP and Fantel AG (1992) Xenobiotics biotransformation/ bioactivation in organogenesis-stage conceptal tissues: Implications for embryotoxicity and teratogenesis. Drug Metab Rev 24:195-238.
23. Khoury MJ, Gomez-Farais M and Mulinaire J (1989) Does maternal cigarette smoking during pregnancy cause cleft lip and palate in offspring? Am J Dis Child 143:333-338.
24. Khoury MJ, Weinstein A, Panny S, Holtzman NA, Lindsay PK, Parrel K and Eisenberg M (1987) Maternal cigarette smoking and oral clefts: A population based study. Am J Public Health 77:295-298.
25. Kirn PM and Wells PG (1996) Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone and benzo(a)pyrene. Cancer Res 56:1526-1532.
26. Laposa RR and Wells PG (1995) Preliminary evaluation of phenytoin teratogenicny in transgenic mice deficient in the p53 tumor suppressor gene. Toxicologist 15:161
27. Law MR and Hackshaw AK (1996) Environmental tobacco smoke. Br Med Bul, 52:22-34.
28. MacDorman MF, Cnattingius S, Hoffman HJ, Kramer MS and Haglund B (1997. Sudden infant death and smoking in the United States and Sweden. Am J Epidemiol 146:249-257.
29. Manchester DK and Jacoby EH (1982) Resolution and reconstruction of human placental monooxygenase activity responsive to maternal cigarette smoking. Dev Pharm Ther 5:162-172.
30. Marnett LJ (1990) Prostaglandin synthase mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates. Environ Health Perspect 88:5-12.
31. Mills NE, Fishman CL, Rom WN, Dubin N and Jacobson DR (1995) Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res 55:1444-1447.
32. Monaghan G, Ryan M, Seddon R, Hume R and Burchell B (1996) Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1:578-581
33. Morse MA, Eklind Kl, Toussaint M, Amin SG and Chung F-L (1990) Characteriza-tion of a glucuronide metabolite of 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis 11:1819-1823.
34. New DAT (1978) Whole embryo culture and the study of mammalian embryos during organogenesis. Biol Rev 53:81-122.
35. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL and Wells PG (1995) A térato-logie suppressor role for p53 in benzopyrene-treated transgenic p53-deficient mice. Nature Genet 10:181-187.
36. Prokopczyk B, Rivenson A and Hoffmann D (1991) A study of betel quid carcinogenesis IX. Comparative carcinogenicity of 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett 60:153-157.
37. Quaife CJ, Pinkert CA, Ornitz DM, Palmiter RD and Brinster RL (1987) Pancreatic neoplastia induced by ras expression in acinar cells of transgenic mice. Cell 62:81-88.
38. Raucy JL and Carpenter SJ (1993) The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J Pharmacol Toxicol Methods 29:121-128.
39. Rodenhuis S and Slebos RJC (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res (Suppl) 52:26658-26698.
40. Ronai ZA, Gradia S, Peterson LA and Hecht SS (1993) G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis 14:2419-2422.
41. Savas U, Bhattacharyya KK, Christou M, Alexander DL and Jefcoate CR (1994) Mouse cytochrome P-450EF, representative of a new IB subfamily of cytochrome P-450s. J Biol Chem 269:14905-14911.
42. Shum S, Jensen NM and Nebert DW (1979) The murine Ah locus: In utero toxicity and teratogenesis associated with genetic differences in benzopyrene metabolism. Teratology 20:365-376.
43. Sipowicz MA, Amin S, Desai D, Kasprzak KS and Anderson LM (1997) Oxidative DNA damage in tissues of pregnant female mice and fetuses caused by the tobacco-specific nitrosamine, 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone (NNK). Cancer Lett 117:87-91.
44. Slamon DJ and Cline MJ (1984) Expression of cellular oncogenes during embryonic and fetal development of the mouse. Proc Natl Acad Sei USA 81:7141-7145.
45. Staples RE and Schnell VL (1964) Refinements in rapid clearing technic in the KOH Alizarin red S method for fetal bone. Stain Technol 39:61-63.
46. Thomas PE, Reik LM, Ryan DE and Levin W (1983) Induction of two rat liver P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. J Biol Chem 258:4590-4598.
47. Walker NJ, Gastel JA, Costa LT, Clark GC, Lucier GW and Sutter TR (1995) Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis 16:1319-1327.
48. Weitberg AB and Corvese D (1993) Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin Genet 43:88-91.
49. Wells PG and Winn LM (1996) Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31:1-40.
50. Winn LM and Wells PG (1995) Phenytoin-initiated DNA oxidation in murine embryo culture, and embryoprotection by the antioxidative enzymes Superoxide dismutase and catalase: Evidence for reactive oxygen species mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol Pharmacol 48:112-120.
51. Winn LM and Wells PG (1997) Evidence for oncogenic K-ras activation in phenytoin teratogenicity in A/J mice. Fundam Appl Toxicol 36(Suppl. 1):303.
52. Winn LM and Wells PG (1998) Increased active GTP-Ras protein in phenytoin exposed mouse embryos: A potential molecular mechanism mediating teratogenesis. Toxicol Sei 42:(Suppl. 1):261.
53. Xu Y, Ho C-T, Amin SG, Han C and Chung F-L (1992) Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res 52:3875-3879.